Yea Christopher 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Yea Christopher（CIK 1691102）在 1 家公司共报告 34 笔 SEC Form 4 内部人交易（最近一笔 2026-06-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 229,918 | $0 |
| 2026-05-29 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 33,800 | $238,966 |
| 2026-05-29 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 33,800 | $905,164 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,125 | $0 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 1,966 | $52,649 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,750 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 2,358 | $63,147 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 1,774 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 1,108 | $29,650 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,125 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,750 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 4,347 | $67,683 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 1,109 | $16,635 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 1,774 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,750 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,125 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 4,331 | $58,252 |
| 2025-11-21 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 87,390 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 4,205 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 2,683 | $38,850 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,125 | $0 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 1,954 | $26,223 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 3,750 | $0 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 卖出 | 2,362 | $31,226 |
| 2025-08-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF DEVELOPMENT OFFICER | 买入 | 4,203 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-11